Holen Sie sich die Stockscreener-App
2.40
5.88%
-0.15
Handel nachbörslich:
2.40
Schlusskurs vom Vortag:
$2.55
Offen:
$2.55
24-Stunden-Volumen:
295.13K
Relative Volume:
1.13
Marktkapitalisierung:
$134.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.38M
KGV:
-6.1538
EPS:
-0.39
Netto-Cashflow:
$-25.19M
1W Leistung:
-14.59%
1M Leistung:
+42.43%
6M Leistung:
+207.65%
1J Leistung:
+140.00%
1-Tages-Spanne:
$2.36
$2.55
1-Wochen-Bereich:
$2.36
$2.87
52-Wochen-Spanne:
$0.51
$3.28
Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile
Firmenname
Connect Biopharma Holdings Ltd
Sektor
Branche
Telefon
858-727-1040
Adresse
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Vergleichen Sie CNTB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.40 | 141.99M | 0 | -21.38M | -25.19M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-01 | Eingeleitet | Lake Street | Buy |
| 2025-10-31 | Eingeleitet | BTIG Research | Buy |
| 2025-06-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-13 | Eingeleitet | Jefferies | Buy |
| 2021-04-13 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-13 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Connect Biopharma Holdings Ltd Aktie (CNTB) Neueste Nachrichten
Analyzing Connect Biopharma (NASDAQ:CNTB) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives $8.50 Average Price Target from Analysts - Defense World
Connect Biopharma (NASDAQ:CNTB) Now Covered by Analysts at Lake Street Capital - MarketBeat
Check Out Connect Biopharma Holdings Ltd (CNTB)’s Trade Data Rather Than the Analysts’ Views - Setenews
Connect Biopharma (NASDAQ:CNTB) Research Coverage Started at Lake Street Capital - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Lake Street Initiates Coverage on Connect Biopharma (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - Daily Review Atlas
Shareholder Panacea Innovation Ltd Files To Sell 2,000,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Taking on analysts’ expectations and winning: Connect Biopharma Holdings Ltd (CNTB) - Setenews
Connect Biopharma Management to Participate in 8th Annual Evercore Healthcare Conference on December 2, 2025 - Quiver Quantitative
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
Shareholder Zheng-Wu Family Trust Files To Sell 650,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Victorville Daily Press
Owner BioFortune Inc Files To Sell 500,000 Of Connect Biopharma Holdings Ltd [CNTB] - TradingView
HC Wainwright Issues Pessimistic Estimate for CNTB Earnings - Defense World
Connect Biopharma Reports Significant Loss Amid Development Efforts - TipRanks
Perhaps timely catching Lazydays Holdings Inc (GORV) would be a good idea - setenews.com
The time has not yet come to remove your chips from the table: Connect Biopharma Holdings Ltd (CNTB) - Setenews
FY2025 EPS Forecast for Connect Biopharma Lowered by Analyst - MarketBeat
Connect Biopharma’s (CNTB) “Buy” Rating Reiterated at BTIG Research - Defense World
Connect Biopharma's (CNTB) Buy Rating Reiterated at BTIG Research - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Announces Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
BTIG Reiterates Buy Rating for CNTB with $10 Price Target | CNTB Stock News - GuruFocus
Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView
[10-Q] Connect Biopharma Holdings Ltd Quarterly Earnings Report | CNTB SEC FilingForm 10-Q - Stock Titan
[8-K] Connect Biopharma Holdings Ltd Reports Material Event | CNTB SEC FilingForm 8-K - Stock Titan
Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN
Relmada Therapeutics Leads These 3 Promising Penny Stocks - Yahoo Finance
Terraphase Acquires Eolas Environmental - The Providence Journal
ADRs Advance; Connect Biopharma Holdings Ltd. Climbs 19% - 富途牛牛
Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential - Investing.com Canada
This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Finanzdaten der Connect Biopharma Holdings Ltd-Aktie (CNTB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):